 Connection
Amit Reddy to Treatment Outcome
This is a "connection" page, showing publications Amit Reddy has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.168 |
|
|
|
-
Shunyakova J, Patnaik JL, Xia J, Hassman LM, Pecen PE, Palestine AG, Reddy AK. Immunomodulatory Therapy Discontinuation for Reasons Other Than Efficacy in the Treatment of Ocular Inflammation. Ocul Immunol Inflamm. 2025 Oct; 33(8):1807-1810.
Score: 0.078
-
Wangyu S, Jung JL, Pecen PE, Palestine AG, Reddy AK. INTRAVITREAL 0.18-mg FLUOCINOLONE ACETONIDE IMPLANT FOR PEDIATRIC UVEITIS. Retina. 2024 10 01; 44(10):1823-1827.
Score: 0.074
-
Sura AA, Sun Y, Reddy AK, Rathinam SR, Gonzales JA, Thundikandy R, Vedhanayaki R, Kanakath A, Murugan B, Doan TA, Lim LL, Suhler EB, Al-Dhibi HA, Acharya NR. Reduced Dose Methotrexate and Mycophenolate Mofetil in Noninfectious Uveitis: A Sub-Analysis from the First-Line Antimetabolites as Steroid Sparing Therapy (FAST) Trial. Ocul Immunol Inflamm. 2024 Aug; 32(6):955-960.
Score: 0.017
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|